XML 99 R84.htm IDEA: XBRL DOCUMENT v3.22.2
Loss Per Common Share - Computation of Earnings per Share (Details) - USD ($)
$ / shares in Units, shares in Thousands, $ in Thousands
 3 Months Ended 6 Months Ended
Jun. 30, 2022
Jun. 30, 2021
Jun. 30, 2022
Jun. 30, 2021
Earnings Per Share [Abstract]        
Loss from continuing operations $ (4,125) $ (9,107) $ (9,475) $ (20,297)
Income (loss) from discontinued operations, net of tax [1] (463) 0 (463) 1,383
Net loss attributable to common shareholders of Evolent Health, Inc. - Basic (4,588) (9,107) (9,938) (18,914)
Net loss attributable to common shareholders of Evolent Health, Inc. - Diluted $ (4,588) $ (9,107) $ (9,938) $ (18,914)
Weighted-average common shares outstanding - basic (in shares) 90,071 85,448 89,792 85,056
Weighted-average common shares outstanding - diluted (in shares) 90,071 85,448 89,792 85,056
Loss per common share, Basic and diluted        
Basic (in dollars per share) $ (0.05) $ (0.11) $ (0.11) $ (0.24)
Continuing operations, diluted (in dollars per share) (0.05) (0.11) (0.11) (0.24)
Discontinued operations, basic (in dollars per share) 0 0 0 0.02
Discontinued operations, diluted (in dollars per share) 0 0 0 0.02
Basic loss per share attributable to common shareholders of Evolent Health, Inc. (in dollars per share) (0.05) (0.11) (0.11) (0.22)
Diluted loss per share attributable to common shareholders of Evolent Health, Inc. (in dollars per share) $ (0.05) $ (0.11) $ (0.11) $ (0.22)
[1] Includes $(0.5) million loss on disposal for the three and six months ended June 30, 2022 and $1.9 million gain on disposal of discontinued operations for the six months ended June 30, 2021, respectively